| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3114865
Max Phase: Preclinical
Molecular Formula: C20H20ClNO5
Molecular Weight: 389.84
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: O=C1N[C@H](C(=O)O)Cc2cccc(c2)OCCCCOc2cccc(Cl)c21
Standard InChI: InChI=1S/C20H20ClNO5/c21-15-7-4-8-17-18(15)19(23)22-16(20(24)25)12-13-5-3-6-14(11-13)26-9-1-2-10-27-17/h3-8,11,16H,1-2,9-10,12H2,(H,22,23)(H,24,25)/t16-/m0/s1
Standard InChI Key: NLUDZQOAPUIKSG-INIZCTEOSA-N
Associated Targets(Human)
Integrin alpha2/beta1 69 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 389.84 | Molecular Weight (Monoisotopic): 389.1030 | AlogP: 3.32 | #Rotatable Bonds: 1 |
| Polar Surface Area: 84.86 | Molecular Species: ACID | HBA: 4 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 3.52 | CX Basic pKa: | CX LogP: 3.45 | CX LogD: 0.08 |
| Aromatic Rings: 2 | Heavy Atoms: 27 | QED Weighted: 0.78 | Np Likeness Score: 0.64 |
References
| 1. Halland N, Blum H, Buning C, Kohlmann M, Lindenschmidt A.. (2014) Small Macrocycles As Highly Active Integrin α2β1 Antagonists., 5 (2): [PMID:24900800] [10.1021/ml4004556] |
Source
Source(1):